From cholesterol regulation to tumor suppression: Pcsk9 as a novel target for cancer immunotherapy.
Publication
, Conference
Bao, X; Liu, X; Hu, M; Chang, H; Jiao, M; Cheng, J; Xie, L; Huang, Q; Li, F; Li, C-Y
Published in: CANCER RESEARCH
2021
Duke Scholars
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
2021
Volume
81
Issue
13
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Bao, X., Liu, X., Hu, M., Chang, H., Jiao, M., Cheng, J., … Li, C.-Y. (2021). From cholesterol regulation to tumor suppression: Pcsk9 as a novel target for cancer immunotherapy. In CANCER RESEARCH (Vol. 81).
Bao, Xuhui, Xinjian Liu, Mengjie Hu, Hanman Chang, Meng Jiao, Jin Cheng, Liyi Xie, Qian Huang, Fang Li, and Chuan-Yuan Li. “From cholesterol regulation to tumor suppression: Pcsk9 as a novel target for cancer immunotherapy.” In CANCER RESEARCH, Vol. 81, 2021.
Bao X, Liu X, Hu M, Chang H, Jiao M, Cheng J, et al. From cholesterol regulation to tumor suppression: Pcsk9 as a novel target for cancer immunotherapy. In: CANCER RESEARCH. 2021.
Bao, Xuhui, et al. “From cholesterol regulation to tumor suppression: Pcsk9 as a novel target for cancer immunotherapy.” CANCER RESEARCH, vol. 81, no. 13, 2021.
Bao X, Liu X, Hu M, Chang H, Jiao M, Cheng J, Xie L, Huang Q, Li F, Li C-Y. From cholesterol regulation to tumor suppression: Pcsk9 as a novel target for cancer immunotherapy. CANCER RESEARCH. 2021.
Published In
CANCER RESEARCH
EISSN
1538-7445
ISSN
0008-5472
Publication Date
2021
Volume
81
Issue
13
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis